Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmexpert, the Moscow-based market research firm, has revealed that the Russian domestic pharmaceutical companies' output increased by just 7% to E1.8 billion in 2007 compared with the 15% growth of imports, according to Scrip World Pharmaceutical News.
Subscribe to our email newsletter
According to Pharmexpert, the antiviral Arbidol, Pentalgin (metamizole sodium, paracetamol, caffeine, codeine phosphate and phenobarbitone) and the enhancer of blood circulation in brain Mexidol (ethylmethylhydroxypyridine succinate), were some of the top selling drugs with shares of 4.5%, 2.6% and 2.3% in total sales.
The pharmaceutical manufacturers Pharmstandard, Valenta and Nizhpharm/Makiz Pharma, Stada’s subsidiaries, bagged the top three positions by the output, with shares of 16.1%, 10.5% and 8.1% respectively in total pharmaceutical sales.
Pharmexpert also found that in the three years to 2007, the average price of a pack of a domestic drug sold in the commercial sector has increased by 70% to E0.5 while that of an imported medicine increased by 55% to E3.05.